YOLFTbeta
Shijiazhuang Yiling Pharmaceutical Co Ltd

Shijiazhuang Yiling Pharmaceutical Co Ltd

002603 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

15.38CNY-0.10 (-0.65%)

Price History

Full chart

Market Stats

Previous Close15.48
Open15.42
Day Range15.34 – 15.59
52-Week Range14.22 – 20.90
Volume10.98M
Market Cap25.65B
P/E (TTM)18.72
Forward P/E58.48
EPS0.82
Dividend Yield5.33%
Beta0.41
50-Day Avg16.18
200-Day Avg16.64

About

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine in China and internationally. It offers dietary supplements, and healthy food and drinks; patent TCM products for respiratory health, cardiovascular disease, diabetes, mellitus, oncology, urologic disease, sleep-improving, and anti-aging; disinfection and personal protective equipment products; and TCM formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Xiang Jun Wu
  • Employees11.34K
  • HeadquartersNo. 238 Tianshan Street, Shijiazhuang, China, 050035, China
  • Websitehttps://www.yiling.cn

Leadership

  • Mr. Xiang Jun WuChairman & GM · b. 1975
  • Mr. Chen Guang LiCFO & Director · b. 1973
  • Ms. Wei WangDeputy GM & Director of Administrative Center · b. 1970
  • Mr. Keyuan ZhangDeputy GM, GM of the Marketing & Non-Independent Director · b. 1967
  • Mr. Wei Dong XuExecutive Deputy Director of the Human Resources Center & Director · b. 1968
  • Dr. Rui WuSecretary of the Board & Non-Independent Director · b. 1980
  • Mr. Xiaolin ZhouDeputy GM & Director of the Supply Center · b. 1970
  • Ms. Liqin CaiAccounting Supervisor

Financials

Income Statement

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue938.56M1.63B1.65B1.95B1.65B2.49B2.92B3.18B3.85B4.08B4.81B5.83B8.78B10.12B12.53B10.32B6.51B7.83B
Growth (%)-+73.92%+1.04%+18.43%-15.59%+51.04%+17.31%+9.02%+20.88%+6.02%+17.97%+20.99%+50.76%+15.19%+23.88%-17.67%-36.88%+20.24%
Cost of Revenue379.73M636.81M554.70M617.69M524.04M830.50M1.07B1.16B1.28B1.30B1.64B2.11B3.12B3.70B4.56B4.43B3.49B2.80B
Gross Profit558.82M995.52M1.09B1.34B1.12B1.66B1.85B2.02B2.57B2.78B3.18B3.72B5.66B6.42B7.98B5.88B3.03B5.03B
Gross Margin59.54%60.99%66.37%68.38%68.21%66.65%63.20%63.44%66.69%68.05%66.02%63.84%64.42%63.43%63.64%57.03%46.47%64.28%
Operating Expense408.45M655.89M748.90M845.93M979.93M1.39B1.44B1.52B1.95B2.13B2.46B3.01B4.22B4.85B5.15B4.10B3.72B3.26B
Operating Income150.37M339.64M345.72M489.59M144.70M273.23M409.99M499.03M612.83M649.56M718.95M710.18M1.44B1.57B2.83B1.78B-688.90M1.78B
Operating Margin16.02%20.81%20.96%25.07%8.78%10.97%14.04%15.67%15.92%15.92%14.93%12.19%16.37%15.51%22.58%17.25%-10.58%22.69%
EBITDA175.71M388.45M420.84M597.89M205.90M295.83M470.63M638.15M837.29M842.93M931.20M910.53M1.69B1.87B3.29B2.15B-236.48M2.22B
EBITDA Margin18.72%23.80%25.52%30.61%12.49%11.88%16.11%20.04%21.75%20.65%19.34%15.63%19.29%18.50%26.28%20.87%-3.63%28.35%
Net Income122.12M297.18M315.56M454.07M185.81M244.29M354.50M430.49M532.69M540.71M599.22M606.50M1.22B1.34B2.36B1.35B-724.52M1.29B
Net Income Margin13.01%18.21%19.13%23.25%11.27%9.81%12.14%13.52%13.84%13.25%12.45%10.41%13.88%13.28%18.85%13.11%-11.12%16.43%
R&D29.08M40.11M-82.17M111.05M156.39M139.75M154.63M187.72M217.44M316.71M390.75M654.39M849.70M1.03B853.19M826.57M718.25M
R&D as % of Total Revenue3.10%2.46%-4.21%6.74%6.28%4.78%4.86%4.88%5.33%6.58%6.71%7.45%8.40%8.23%8.27%12.69%9.17%
Interest Expense1.74M2.02M7.91M20.20M6.88M226.56K3.13M5.23M5.09M10.53M1.00M6.58M12.32M33.97M50.35M38.90M41.21M1.06M
Interest Expense % of Total Revenue0.19%0.12%0.48%1.03%0.42%0.01%0.11%0.16%0.13%0.26%0.02%0.11%0.14%0.34%0.40%0.38%0.63%0.01%

Balance Sheet

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets831.91M1.51B1.77B4.23B4.17B4.66B5.09B5.71B6.26B7.89B8.56B9.07B11.51B12.90B16.34B16.98B13.32B13.67B
Total Liabilities347.88M718.89M680.08M523.78M320.75M399.69M671.19M879.56M925.04M775.58M993.56M1.12B2.58B3.83B5.41B5.54B3.12B2.69B
Total Equity481.50M787.69M1.09B3.70B3.84B4.26B4.42B4.82B5.32B7.11B7.56B7.94B8.92B9.07B10.93B11.45B10.22B10.99B
Cash126.13M210.84M403.09M1.96B1.50B709.63M401.53M430.59M548.07M802.68M777.26M733.41M1.34B995.26M1.90B940.51M853.03M1.10B
Total Debt30.00M-206.00M202.00M47.00M--50.00M100.00M--50.05M280.72M1.01B715.47M1.21B18.21M-
Net Debt-96.13M-210.84M-197.09M-1.76B-1.45B-709.63M-401.53M-380.59M-448.07M-802.68M-777.26M-683.36M-1.06B18.21M-1.19B271.95M-834.82M-

Cash Flow

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow210.18M318.21M299.72M-408.49M70.13M55.32M105.90M131.88M641.45M114.65M72.37M68.93M1.59B528.69M3.49B155.46M611.01M1.78B
Investing Cash Flow-128.08M-210.57M-307.15M-177.88M-296.69M-885.94M-353.75M-105.00M-504.94M-952.55M46.37M37.12M-1.04B-506.76M-1.99B-899.22M1.61B-
Financing Cash Flow-19.24M-22.94M199.69M2.15B-236.91M41.16M-60.31M2.40M-23.34M1.09B-143.85M-169.59M-23.26M-302.15M-637.00M-220.59M-2.25B-
Capital Expenditure128.27M210.57M285.02M177.90M296.89M409.83M450.19M478.43M373.03M180.35M187.23M454.43M1.14B673.56M213.98M310.83M290.39M245.62M
Free Cash Flow81.91M107.64M14.70M-586.38M-226.76M-354.51M-344.29M-346.56M258.61M-65.69M-114.86M-385.50M441.39M-144.87M3.27B-155.38M320.62M1.53B
Dividends Paid83.74M1.94M4.81M56.10M35.91M56.05M55.24M58.36M86.86M103.06M120.63M119.78M238.67M1.19B282.70M835.35M375.31M501.21M
FCF to OCF38.97%33.83%4.90%143.55%-323.35%-640.80%-325.09%-262.79%40.32%-57.30%-158.72%-559.30%27.83%-27.40%93.86%-99.95%52.47%86.17%
Dividend Paid to FCF102.24%1.80%32.73%-9.57%-15.84%-15.81%-16.04%-16.84%33.59%-156.88%-105.02%-31.07%54.07%-823.77%8.64%-537.63%117.06%32.74%

Earnings

Report DateSep 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Oct 26, 2012Feb 27, 2013Apr 25, 2013Aug 28, 2013Oct 28, 2013Feb 26, 2014Apr 24, 2014Aug 26, 2014Oct 27, 2014Feb 13, 2015Apr 27, 2015Aug 24, 2015Oct 29, 2015Feb 26, 2016Apr 25, 2016Aug 22, 2016Oct 27, 2016Feb 22, 2017Apr 24, 2017Aug 24, 2017Oct 27, 2017Feb 26, 2018Apr 25, 2018Aug 23, 2018Oct 29, 2018Feb 27, 2019Apr 24, 2019Aug 26, 2019Oct 29, 2019Feb 27, 2020Apr 28, 2020Aug 27, 2020Oct 26, 2020Apr 28, 2021Aug 25, 2021Oct 28, 2021Apr 28, 2022Aug 25, 2022Oct 27, 2022Apr 25, 2023Aug 28, 2023Oct 27, 2023Apr 26, 2024Aug 28, 2024Oct 28, 2024Apr 29, 2025Aug 28, 2025Oct 29, 2025Apr 29, 2026Aug 29, 2026
EPS Estimate----0.08-0.06-0.04-0.070.090.060.060.060.070.110.130.070.080.110.090.080.120.080.100.070.090.050.080.080.070.05---------------------
EPS Actual0.080.110.050.040.010.020.050.050.050.010.060.090.060.040.080.060.100.090.120.090.110.090.140.090.060.080.060.120.060.030.170.100.070.010.370.160.180.410.170.160.070.340.220.720.240.090.180.140.01-0.770.210.200.240.21
Surprise-----87.50%--16.67%-25.00%--14.29%0.00%0.00%-33.33%33.33%-14.29%-9.09%-30.77%71.43%12.50%0.00%0.00%75.00%-25.00%-25.00%-20.00%-14.29%33.33%20.00%-62.50%112.50%42.86%40.00%---------------------
Timing----After-hours-After-hours-After-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-marketPre-market----

Key Statistics & Ratios

Market Cap25.65B
Enterprise Value23.73B
Trailing P/E18.72
Forward P/E58.48
PEG Ratio0.00
Price / Sales3.26
Price / Book2.37
EPS0.82
Book Value6.53
Revenue (TTM)7.87B
Gross Profit (TTM)5.13B
EBITDA2.31B
Profit Margin17.49%
Operating Margin24.24%
Return on Equity12.62%
Return on Assets7.49%
Shares Outstanding1.67B
Shares Float732.50M
Beta0.41
Dividend Yield5.33%
Dividend Rate0.80
Payout Ratio122.72%

Dividends

20261×
0.50Jun 16, 2026
20251×
0.30Oct 22, 2025
20241×
0.30Jul 19, 2024
20231×
0.50Jul 17, 2023
20221×
0.30Jul 19, 2022
20211×
0.71Jul 7, 2021
20201×
0.14Jun 2, 2020
20191×
0.07Jul 1, 2019
20181×
0.07Jul 2, 2018
20171×
0.07Jun 12, 2017
20161×
0.07Jun 14, 2016
20151×
0.04May 20, 2015
20141×
0.04Jun 30, 2014
20131×
0.04Jun 7, 2013
20121×
0.03Jun 11, 2012

Stock Splits

  • Jul 7, 20211.4:1
  • May 20, 201520:10
  • Jun 11, 201213:10